Roxana Schillaci

Roxana Schillaci

Company: Institute of Biology and Experimental Medicine CONICET, Argentina

Job title: Principal Researcher

Seminars:

Resistance to Immunotherapy Caused by MUC4 Expression in HER2+ Tumors – Bench to Bedside 12:30 pm

• Exploring how MUC4 expression predicts resistance to immunotherapy • Targeting soluble TNF reverses resistance in animal models • Understand how knowing the MUC4 status of a patient’s tumor will improve clinical decision making and should benefit patient outcomeRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.